We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGHC
3551
DELISTED
National General Holdings Corp
NGHC
$1.98M ﹤0.01%
89,602
+31,648
+55% +$692K
FRPT icon
3552
Freshpet
FRPT
$3.22B
$1.98M ﹤0.01%
33,486
+6,141
+22% +$327K
NMM icon
3553
Navios Maritime Partners
NMM
$2.26B
$1.98M ﹤0.01%
106,240
+11,428
+12% +$213K
BXMT icon
3554
PUT
Blackstone Mortgage Trust
BXMT
$2.38B
$1.98M ﹤0.01%
+53,100
New +$1.93M
PFN
3555
PIMCO Income Strategy Fund II
PFN
$703M
$1.98M ﹤0.01%
186,528
-1,458
-0.8% -$15.3K
DIV icon
3556
Global X SuperDividend US ETF
DIV
$783M
$1.97M ﹤0.01%
83,165
-21,377
-20% -$500K
VTC icon
3557
Vanguard Total Corporate Bond ETF
VTC
$1.71B
$1.97M ﹤0.01%
22,284
+1,567
+8% +$138K
ABMD
3558
DELISTED
Abiomed Inc
ABMD
$1.97M ﹤0.01%
11,554
-12,834
-53% -$2.38M
JUST icon
3559
Goldman Sachs JUST US Large Cap Equity ETF
JUST
$579M
$1.97M ﹤0.01%
42,509
+86
+0.2% +$3.81K
RDFN
3560
DELISTED
Redfin
RDFN
$1.97M ﹤0.01%
93,066
+7,656
+9% +$147K
PPC icon
3561
CALL
Pilgrim's Pride
PPC
$6.54B
$1.96M ﹤0.01%
+59,900
New +$1.86M
UTL icon
3562
Unitil
UTL
$980M
$1.96M ﹤0.01%
31,676
+7,163
+29% +$443K
BPMC
3563
DELISTED
Blueprint Medicines
BPMC
$1.95M ﹤0.01%
24,366
-35,564
-59% -$2.66M
SFL icon
3564
SFL Corp
SFL
$1.61B
$1.95M ﹤0.01%
134,237
-520,090
-79% -$7.52M
OFS icon
3565
OFS Capital
OFS
$51.9M
$1.95M ﹤0.01%
174,512
-7,498
-4% -$86.8K
SSTK icon
3566
PUT
Shutterstock
SSTK
$219M
$1.95M ﹤0.01%
+45,400
New +$1.82M
TRI icon
3567
Thomson Reuters
TRI
$44.1B
$1.95M ﹤0.01%
25,788
-6,577
-20% -$479K
CBH
3568
DELISTED
Virtus Convertible & Income 2024 Target Term Fund
CBH
$1.95M ﹤0.01%
201,479
-29,841
-13% -$287K
BRKL
3569
DELISTED
Brookline Bancorp
BRKL
$1.94M ﹤0.01%
117,564
+23,364
+25% +$368K
FBM
3570
PUT
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$1.94M ﹤0.01%
+100,000
New +$1.92M
ASND icon
3571
Ascendis Pharma A/S
ASND
$16.8B
$1.93M ﹤0.01%
13,903
+6,969
+101% +$774K
STAA icon
3572
STAAR Surgical
STAA
$1.21B
$1.93M ﹤0.01%
54,969
+22,126
+67% +$730K
PKO
3573
DELISTED
Pimco Income Opportunity Fund
PKO
$1.93M ﹤0.01%
69,538
-2,343
-3% -$64K
AIO
3574
Virtus Artificial Intelligence & Technology Opportunities Fund
AIO
$903M
$1.93M ﹤0.01%
+96,020
New +$1.92M
SPMD icon
3575
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.9B
$1.93M ﹤0.01%
53,258
+541
+1% +$18.9K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.